Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
Dodeca (lithium, sodium)-2-({4-[4-(4-{bis[alkyl-(sulfonatoalkoxy)-4-({-sulfonato-[(substituted-phenyl)diazenyl]phenyl} diazenyl)anilino]-triazin-yl}-6-[alkyl-(sulfonatoalkoxy)-4-(sulfonato--[(substituted-phenyl)diazenyl]phenyl)diazenyl)anilino]piperazin-yl)-triazin-ylamino]-alkyl-5-(sulfonatoalkoxy)phenyl}diazenyl)-5-[(sulfonatophenyl)diazenyl]benzensulfonate
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- July 21 - September 30, 2010
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: The study has been performed according to OECD and/or EC guidelines and according to GLP principles.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 010
- Report date:
- 2010
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- acute toxic class method
- Limit test:
- no
Test material
Reference
- Name:
- Unnamed
- Type:
- Constituent
- Details on test material:
- - Name of test material (as cited in study report): E-BW102
- Physical state: Reddish brown powder
- Storage condition of test material: Room temperature (actual temperature: 19.3 to 22.7°C), dark place
- Stability under storage conditions: Not indicated
Test animals
- Species:
- rat
- Strain:
- other: Crl:CD(SD)
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- - Source: Charles River Laboratories Japan, Inc. (Hino breeding center)
- Age at study initiation: Young adult animals (9 weeks old)
- Weight at study initiation: Body weight variation was within +/- 20% of the sex mean (200.6-229.7g).
- Housing: Individual 1 animal per cage in labeled Stainless-steel cages (226x346x198mm).
- Diet (e.g. ad libitum): Free access to pellet diet (CRF-1, Oriental Yeast Co., Ltd.)
- Water (e.g. ad libitum): Free access to well water.
- Acclimation period: The acclimatization period was 6 days for experiement 1 and 8 days for experiment 2.
- Health inspection: During the acclimation period, the animals were examined for clinical signs once daily and body weights twice to confirm their health status.
Data for each lot of diet generated by Japan Food Research Laboratories was provided by Oriental Yeast Co., Ltd., and the contaminants in the diet were confirmed to be within the acceptable limits established by the test facility.
The water was analyzed every 6 months at Nichigo Kyushu Co., Ltd. in compliance with the Water Quality Standard (Waterworks Law) of MHLW, Japan.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 23.6 – 24.6
- Humidity (%): 44.9 - 61.3
All housing equipment was sterilized by autoclaving after washing with water. The floor of the animal room was cleaned and wiped every day with a disinfectant-soaked mop. NaClO was used as the disinfectants on every day.
- Air changes (per hr): 10 to 20 per hour
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES: From: August 03, 2010 to August 19, 2010
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
GAVAGE METHOD: disposable syringe
Frequency: single dosage, on Day 1.
VEHICLE
- Justification for choice of vehicle: No data.
MAXIMUM DOSE VOLUME APPLIED: 2000 mg/kg (25 mL/kg) body weight.
DOSAGE PREPARATION: The test substance was weighed and transferred to a measuring cylinder. Vehicle of about 80% of the preparation volume was added to the measuring cylinder and dissolved by ultrasonic irradiation. The solution was added up to the preparation volume and mixed upside down. The dosing solution was transferred into a brown glass container.- Doses:
- 2000 mg/kg body weight
- No. of animals per sex per dose:
- 6 (2 groups of three females in a stepwise manner (experiment 1 and 2))
- Control animals:
- no
- Details on study design:
- Animals were fasted for approximately 18 to 19 hours from the evening on the day before the administration until 3 hours after administration of the test substance. Water was available ad libitum.
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing:
Mortality and clinical signs: Before dosing (Day 1) and at 30 minutes, 1, 3 and 5 hours postdose on the day of the administration and once daily for 14 days thereafter.
Body weights: All animals were subjected to the body weight measurement just before the administration (Day 1) and on Days 4, 8 and 15. Moreover, the body weight gain between each measurement day was calculated.
- Necropsy of survivors performed: At the end of the 15-day observation period, all animals were euthanized by exsanguination from the external iliac artery under intraperitoneal sodium pentobarbital (30 mg/kg) anesthesia and were examined macroscopically.
- Other examinations performed: none - Statistics:
- No statistical analysis was performed (The method used is not intended to allow the calculation of a precise LD50 value).
Results and discussion
Effect levels
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No death was noted in any animal.
- Clinical signs:
- Test substance-mixed feaces was observed in all animals from 0.5 or 1 hour on day 1 (administration day) to Day 3 or 4 and chromaturia (reddish brown) was observed in all animals from Day 2 to Day 3 or 4 in experiment 1 and 2. Furthermore, soiled periproctal was observed in 1 animal on Day 3 and 4 in experiment 1. The test substance is a reddish brown-powder, therefore, the feaces and chromaturia were attributed to the test substance. In addition, soiled periproctal observed in 1 animal in experiment 1 was possibly a secondary effect associated with the feaces and chromaturia.
- Body weight:
- Although a decrease in the body weight was noted in 1 animal on day 4in experiment 1, an increase was observed thereafter. No abnormalities were noted in body weight gain in the remaining 2 animals in experiment 1 and any animal in experiment 2.
- Gross pathology:
- No abnormalities were noted in any animal.
- Other findings:
- None.
Any other information on results incl. tables
Deviations from the protocol:
In the protocol, the animals were to be fasted for approximately 18 hours predose, however, the animals were actually fasted for approximately 19 hours in experiment 1. The result of experiment 1 was comparable to that of experiment 2, in which the animals were fasted for approximately 18 hours. Therefore, the prolongation of the fasting time (1 hour) was considered to have no effect on the study result.
Applicant's summary and conclusion
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- In an acute oral toxicity study performed according to OECD 423 and GLP, the LD50 value of E-BW102 in female rats was established to exceed 2000 mg/kg body weight.
According to Regulation (EC) No. 1272/2008, E-BW102 needs not to be classified for acute oral toxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
